Incyte Biosciences Japan Gk
Clinical trials sponsored by Incyte Biosciences Japan Gk, explained in plain language.
-
New drug cocktails tested in fight against lymphoma
Disease control OngoingThis study is testing several combinations of a new drug called tafasitamab with other cancer medications in Japanese adults with Non-Hodgkin Lymphoma. It aims to find safe and effective treatment options for people whose cancer has come back or is newly diagnosed. The main goals…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Apr 04, 2026 01:35 UTC
-
New hope for patients battling severe transplant complication
Disease control OngoingThis study is testing a drug called axatilimab for Japanese patients with chronic graft-versus-host disease (cGVHD) that has come back or hasn't improved after at least two prior treatments. The goal is to see if the drug can reduce the severity of the disease and improve symptom…
Phase: PHASE3 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC